€26.80
0.74% yesterday
Xetra, May 20, 05:36 pm CET
ISIN
DE000A2P4LJ5
Symbol
PSG
Index
Sector
Industry

Pharmasgp Holding Stock price

€26.80
+2.80 11.67% 1M
+3.00 12.61% 6M
+1.80 7.20% YTD
+4.00 17.54% 1Y
+2.50 10.29% 3Y
-7.70 22.32% 5Y
-7.70 22.32% 10Y
Xetra, Closing price Tue, May 20 2025
-0.20 0.74%
ISIN
DE000A2P4LJ5
Symbol
PSG
Index
Sector
Industry

Key metrics

Market capitalization €308.54m
Enterprise Value €348.39m
P/E (TTM) P/E ratio 16.29
EV/FCF (TTM) EV/FCF 16.58
EV/Sales (TTM) EV/Sales 2.93
P/S ratio (TTM) P/S ratio 2.60
P/B ratio (TTM) P/B ratio 9.65
Dividend yield 1.90%
Last dividend (FY25) €0.51
Revenue growth (TTM) Revenue growth 17.55%
Revenue (TTM) Revenue €118.84m
EBIT (operating result TTM) EBIT €27.89m
Free Cash Flow (TTM) Free Cash Flow €21.01m
Cash position €26.49m
EPS (TTM) EPS €1.65
P/S forward 2.50
EV/Sales forward 2.82
Show more

Is Pharmasgp Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Pharmasgp Holding Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Pharmasgp Holding:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Pharmasgp Holding:

Buy
100%

Financial data from Pharmasgp Holding

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
119 119
18% 18%
100%
- Direct Costs 28 28
8% 8%
24%
91 91
21% 21%
76%
- Selling and Administrative Expenses 53 53
30% 30%
45%
- Research and Development Expense - -
-
-
37 37
9% 9%
31%
- Depreciation and Amortization 9.41 9.41
0% 0%
8%
EBIT (Operating Income) EBIT 28 28
13% 13%
23%
Net Profit 20 20
19% 19%
16%

In millions EUR.

Don't miss a Thing! We will send you all news about Pharmasgp Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pharmasgp Holding Stock News

AD HOC NEWS
about one month ago
PharmaSGP Holding SE / DE000A2P4LJ5

Company Profile

PharmaSGP Holding SE engages in the manufacture of non-chemical, over-the-counter pharmaceutical products. Its product brands include RubaXX, Restaxil, FULMINAN, DESEO, Neradin, and TAUMEA. The company is headquartered in Gräfelfing, Germany.

Head office Germany
CEO Peter Gerckens
Employees 91
Founded 2012
Website www.pharmasgp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today